Abstract
Responsible for causing a series of congenital diseases in humans, such as microcephaly in newborns and Guillain-Barré syndrome in adults, the Zika virus (ZIKV) began to spread throughout the Americas in 2015, quickly becoming a public health problem in at least 33 countries on the continent. This epidemic generated demand for the formulation of prevention against this infectious agent. I…